title: Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.
abstract: Thirty patients with hypercalcaemia due to malignancy that persisted following rehydration, were treated with a single dose of the bisphosphonate, clodronate. Clodronate (1.5 g) was administered intravenously in 500 ml normal saline over 4 h. Serum and urine biochemistry were measured before and after treatment and the results were compared with data from 15 patients given the recommended regimen 300 mg intravenous clodronate daily for 5 consecutive days. The single infusion induced a rapid and significant fall in serum calcium, apparent at day 3 (P < 0.0001) that persisted to the end of follow-up at day 10 (P < 0.001). Eighty per cent (24/30) of patients became normocalcaemic. The response was associated with a significant decrease in fasting urinary calcium excretion, and no change in renal function, as judged by serum creatinine. The same dose of clodronate, given as 5 daily infusions, induced a comparable decrease in serum calcium, but was less rapid in onset so that at day 3 the serum calcium was significantly lower with the single infusion (P = 0.02). The calcium lowering effect of both regimens depended on the tumour type. We conclude that the single infusion of 1500 mg clodronate is as effective in reducing serum calcium as the same dose given over 5 days. The single infusion has a more rapid onset of effect, is more convenient than multiple infusions, and has no adverse effect on renal function.
authors.affiliation: Department of Human Metabolism and Clinical Biochemistry, University of Sheffield Medical School, UK.
authors.forename: N P
authors.initials: NP
authors.lastname: O'Rourke
authors.forename: E V
authors.initials: EV
authors.lastname: McCloskey
authors.forename: S
authors.initials: S
authors.lastname: Vasikaran
authors.forename: K
authors.initials: K
authors.lastname: Eyres
authors.forename: D
authors.initials: D
authors.lastname: Fern
authors.forename: J A
authors.initials: JA
authors.lastname: Kanis
mesh_terms: D000328:Adult; D000368:Aged; D002118:Calcium / Q000097:blood; D004002:Clodronic Acid / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000150:complications*
chemical_list: D004002:Clodronic Acid; D002118:Calcium